These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
361 related items for PubMed ID: 9431316
1. Localized amyloidosis of the seminal vesicle. Possible association with hormonally treated prostatic adenocarcinoma. Unger PD, Wang Q, Gordon RE, Stock R, Stone N. Arch Pathol Lab Med; 1997 Dec; 121(12):1265-8. PubMed ID: 9431316 [Abstract] [Full Text] [Related]
2. [Amyloidosis localized in the seminal vesicles: clinico-pathological review of 8 cases diagnosed in surgical specimens]. Caballero Martínez MC, Gómez Dorronsoro ML, Cuesta Alcalá JA, Amat Villegas I, Beloqui Pérez R, Martínez Peñuela JM, Monzón Muñoz FJ. Arch Esp Urol; 2003 May; 56(4):431-4. PubMed ID: 12830618 [Abstract] [Full Text] [Related]
3. Characterization of localized seminal vesicle amyloidosis causing hemospermia: an analysis using immunohistochemistry and magnetic resonance imaging. Furuya S, Masumori N, Furuya R, Tsukamoto T, Isomura H, Tamakawa M. J Urol; 2005 Apr; 173(4):1273-7. PubMed ID: 15758775 [Abstract] [Full Text] [Related]
4. Localized amyloidosis of seminal vesicles: report of three cases in surgically obtained material. Seidman JD, Shmookler BM, Connolly B, Lack EE. Mod Pathol; 1989 Nov; 2(6):671-5. PubMed ID: 2587572 [Abstract] [Full Text] [Related]
5. Amyloidosis of the seminal vesicle--a case report and review of the literature. Maroun L, Jakobsen H, Kromann-Andersen B, Horn T. Scand J Urol Nephrol; 2003 Nov; 37(6):519-21. PubMed ID: 14675929 [Abstract] [Full Text] [Related]
6. The distribution of PAX-2 immunoreactivity in the prostate gland, seminal vesicle, and ejaculatory duct: comparison with prostatic adenocarcinoma and discussion of prostatic zonal embryogenesis. Quick CM, Gokden N, Sangoi AR, Brooks JD, McKenney JK. Hum Pathol; 2010 Aug; 41(8):1145-9. PubMed ID: 20413145 [Abstract] [Full Text] [Related]
7. [Amyloidosis of the seminal vesicles: a local condition with no systemic impact]. Harvey I, Têtu B. Ann Pathol; 2004 Jun; 24(3):236-40; quiz 227. PubMed ID: 15480258 [Abstract] [Full Text] [Related]
8. Seminal vesicle amyloidosis does not provide any protection from invasion by prostate cancer. Erbersdobler A, Kollermann J, Graefen M, Röcken C, Schlomm T. BJU Int; 2009 Feb; 103(3):324-6. PubMed ID: 18778344 [Abstract] [Full Text] [Related]
9. Androgen receptor modulation in benign human prostatic tissue and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy. Van der Kwast TH, Têtu B, Fradet Y, Dupont A, Gomez J, Cusan L, Diamond P, Labrie F. Prostate; 1996 Apr; 28(4):227-31. PubMed ID: 8602398 [Abstract] [Full Text] [Related]
14. [Current value of seminal vesicle biopsy in patients with prostate cancer and influence of radical prostatectomy in patients with seminal vesicle invasion]. Losa CA, Fernando AB, Lázaro VA, Berlanga FF, Frago PS, López MA, Sanz MJ, Martínez PG, Sanz LA. Arch Esp Urol; 2006 Dec; 59(10):977-88. PubMed ID: 17283711 [Abstract] [Full Text] [Related]
16. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Teh BS, Ayala G, Aguilar L, Mai WY, Timme TL, Vlachaki MT, Miles B, Kadmon D, Wheeler T, Caillouet J, Davis M, Carpenter LS, Lu HH, Chiu JK, Woo SY, Thompson T, Aguilar-Cordova E, Butler EB. Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1520-9. PubMed ID: 15050332 [Abstract] [Full Text] [Related]
17. Alpha-methylacyl-CoA racemase (P504S)/34betaE12/p63 triple cocktail stain in prostatic adenocarcinoma after hormonal therapy. Sung MT, Jiang Z, Montironi R, MacLennan GT, Mazzucchelli R, Cheng L. Hum Pathol; 2007 Feb 01; 38(2):332-41. PubMed ID: 17134736 [Abstract] [Full Text] [Related]